---
title: "AIM IMMUNOTECH INC (AIMID.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/AIMID.US/norm.md"
symbol: "AIMID.US"
name: "AIM IMMUNOTECH INC"
parent: "https://longbridge.com/en/quote/AIMID.US.md"
datetime: "2026-03-08T04:08:52.158Z"
locales:
  - [en](https://longbridge.com/en/quote/AIMID.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AIMID.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AIMID.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/AIMID.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/AIMID.US/norm.md)


# AIM IMMUNOTECH INC (AIMID.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -5.27 | -9.32 | -6.42 | -3.47 | -11.76 |
| ROE | 572.31% | -3002.26% | -328.38% | -143.45% | -340.13% |
| Revenue | 16000.00 | 45000.00 | 35000.00 | 50000.00 | 40000.00 |
| Net income | -3.71M | -5.97M | -3.70M | -1.84M | -5.82M |

## Balance Sheet (USD)

| Indicator | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 6.25M | 8.61M | 13.59M | 15.71M | 16.19M |
| Leverage | -1.62 | -6.51 | 4.67 | 2.58 | 3.35 |
| BVPS | -5.34 | -2.02 | 4.96 | 10.68 | 8.23 |
| Turnover | 0.0130 | 0.0121 | 0.0092 | 0.0081 | 0.0072 |

## Cash Flow Statement (USD)

| Indicator | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -2.36M | -3.96M | -3.11M | -3.01M | -4.82M |
| Investing CF | 898000.00 | 3.70M | 334000.00 | 826000.00 | -158000.00 |
| Financing CF | 660000.00 | 1.04M | 137000.00 | 2.44M | 2.83M |
| Free CF | -1.74M | -3.64M | -1.95M | -4.09M | -2.79M |